Guanglin Wang

Building 4, 720 Cailun Road, Zhang Jiang Hi Tech Park
Zhangjiang, 201203, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

PSMA and Integrin αvβ3 Dual-Targeted Radioligands for Prostate Cancer Targeted Radionuclide Therapy.

PSMA and Integrin αvβ3 Dual-Targeted Radioligands for Prostate Cancer Targeted Radionuclide Therapy.

Journal: Journal of medicinal chemistry

Published: July 27, 2026

Dual-Targeted Radionuclide Therapy with 161Tb Instigates Anticancer Immunity in "Cold" Murine Prostate Tumor.

Dual-Targeted Radionuclide Therapy with 161Tb Instigates Anticancer Immunity in "Cold" Murine Prostate Tumor.

Journal: Molecular pharmaceutics

Published: July 03, 2026

Research on the effect of N-acetylcysteine on ROS/NLRP3-mediated pyroptosis in BEAS-2B Cells and bronchial epithelial tissues from patients with AECOPD.

Research on the effect of N-acetylcysteine on ROS/NLRP3-mediated pyroptosis in BEAS-2B Cells and bronchial epithelial tissues from patients with AECOPD.

Journal: Immunobiology

Published: April 28, 2026

Development of a CD9-Targeted Radiopharmaceutical for Imaging and Radionuclide Therapy in CD9-Positive Glioma.

Development of a CD9-Targeted Radiopharmaceutical for Imaging and Radionuclide Therapy in CD9-Positive Glioma.

Journal: Molecular pharmaceutics

Published: September 20, 2025

131I/MTX-loaded engineered outer membrane vesicles for sequentially coordinated radio-metabolic-immunotherapy of glioma.

131I/MTX-loaded engineered outer membrane vesicles for sequentially coordinated radio-metabolic-immunotherapy of glioma.

Journal: Journal of nanobiotechnology

Published: September 15, 2025

Click Covalent-Targeted Radionuclide Therapy for Prostate Cancer.

Click Covalent-Targeted Radionuclide Therapy for Prostate Cancer.

Journal: Journal of medicinal chemistry

Published: August 11, 2025

Radio-magnetic dual-functional microspheres for magnetic hyperthermia therapy combined with radioembolization of hepatocellular carcinoma.

Radio-magnetic dual-functional microspheres for magnetic hyperthermia therapy combined with radioembolization of hepatocellular carcinoma.

Journal: Materials today. Bio

Published: August 06, 2025

Sequence-regulated, lung-targeting heteropolypeptide nanoparticles via in situ erythrocyte hitchhiking.

Sequence-regulated, lung-targeting heteropolypeptide nanoparticles via in situ erythrocyte hitchhiking.

Journal: Nature communications

Published: July 31, 2025

A ZIF-8-based dual-modal smart responsive nanoplatform for overcoming radiotherapy resistance in advanced tumors.

A ZIF-8-based dual-modal smart responsive nanoplatform for overcoming radiotherapy resistance in advanced tumors.

Journal: Nanoscale

Published: April 29, 2025

Radionuclide-Labeled Biomaterials: A Novel Strategy for Tumor-Targeted Therapy.

Radionuclide-Labeled Biomaterials: A Novel Strategy for Tumor-Targeted Therapy.

Journal: Biomimetics (Basel, Switzerland)

Published: April 21, 2025

Dual-targeted alpha therapy mitigates prostate cancer and boosts immune checkpoint blockade therapy.

Dual-targeted alpha therapy mitigates prostate cancer and boosts immune checkpoint blockade therapy.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: February 01, 2025

Discovery of HMPL-306 (Ranosidenib), a New Potent and Selective Dual Inhibitor of Mutant IDH1 and 2 in Clinical Development for Cancer Treatment.

Discovery of HMPL-306 (Ranosidenib), a New Potent and Selective Dual Inhibitor of Mutant IDH1 and 2 in Clinical Development for Cancer Treatment.

Journal: ACS medicinal chemistry letters

Published: December 25, 2024

Showing 1-12 of 42

Last Updated: 09/26/2026